A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/26/2002	US6486189 Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/26/2002	US6486188 Method of treatment for cardiovascular complications
11/26/2002	US6486187 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
11/26/2002	US6486186 Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
11/26/2002	US6486184 1-(cyclopentyloxy-(3,4-dichloro- phenyl)-acetyl)-3-methyl-urea for example; use in treating hyperglycemia characteristic of all type ii diabetes
11/26/2002	US6486183 Antivirals
11/26/2002	US6486182 Mutual prodrugs of amlodipine and atorvastatin
11/26/2002	US6486181 Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
11/26/2002	US6486179 Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
11/26/2002	US6486177 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
11/26/2002	US6486172 Quinuclidine-substituted aryl compounds for treatment of disease
11/26/2002	US6486171 Useful in the treatment of some central nervous system disorders including as an antidepressant; 4-(1-(2-naphthyl)ethyl)-4- piperidinyl)thieno(3,2-c)pyridine, for example
11/26/2002	US6486170 Phospholipase A2 inhibitors as mediators of gene expression
11/26/2002	US6486169 Botanical drug for treatment and prevention of alzhimer's disease
11/26/2002	US6486168 Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
11/26/2002	US6486167 Heterocyclic cytotoxic agents
11/26/2002	US6486166 Suppression of cyclin kinase 2 activity for prevention and treatment of DNA viral infections
11/26/2002	US6486165 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/26/2002	US6486162 2-{3-[4-(2-t-butyl-6-trifluoromethyl-4-pyrimidinyl)-1- piperazinyl] propylthio}-4-pyrimidinol fumarate
11/26/2002	US6486161 Use of rifamycin derivative for treating mastitis in a domestic animal
11/26/2002	US6486156 Chemical compounds
11/26/2002	US6486155 Method of inhibiting neoplastic cells with isoquinoline derivatives
11/26/2002	US6486154 (Hetero) aryl-sulfonamide derivatives, their preparation and their use as factor XA inhibitors
11/26/2002	US6486152 Topical carbamazepine formulations and methods of use
11/26/2002	US6486151 N-oxides of heterocyclic esters, amides, thioesters, and ketones
11/26/2002	US6486150 Process for formulation of antibiotic compounds
11/26/2002	US6486149 Dissolving crystalline cefditoren pivoxil substance and the water-soluble high-molecular additive in an aqueous solution of an acid, then neutralizing the resultant solution, to co-precipitate product, and drying
11/26/2002	US6486148 Sensitize bacteria to other antibiotics; include at least two groups selected from (protected)aminoalkoxy(carbonyl), aminoalkylaminocarbonyl, aminoalkylcarbonylamino, azidoalkoxy, guanidinoalkoxy(carbonyl), and cyanoalkoxy
11/26/2002	US6486147 Cosmetic composition containing a steroid and a 2-alkylalkanol or an ester thereof
11/26/2002	US6486146 Cancer accelerants and phase synchronization methods
11/26/2002	US6486145 Meiosis regulating compounds
11/26/2002	US6486144 Method of treatment of liver tumors and pharmaceutical compositions for use therein
11/26/2002	US6486143 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds
11/26/2002	US6486142 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002	US6486141 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002	US6486140 Agents, and methods employing them, for the prevention or reduction of tissue adhesion at a wound site
11/26/2002	US6486139 Ophthalmic solution comprising glycogen
11/26/2002	US6486138 Ophthalmic compositions containing galactomannan polymers and borate
11/26/2002	US6486137 Oligosaccharide mixtures having antithrombotic activity
11/26/2002	US6486136 Combinations comprising VX478, zidovudine and/or 1592U89 for use in the treatment of HIV
11/26/2002	US6486132 Immunomodulator, immunomodulator food and immunomodulator feed
11/26/2002	US6486131 As diagnostic and therapeutic assays and reagents for detecting and therapy of proliferative disorders arising from, for example, tumorigenic transformation of cells, or other hyperplastic or neoplastic transformation processes
11/26/2002	US6486128 Method of using emamectin to treat fish parasites
11/26/2002	US6486127 Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof
11/26/2002	US6486126 Antioxidant activity in SDG metabolites
11/26/2002	US6486125 Synthesis of soluble β-sheet forming peptides
11/26/2002	US6486122 Methods of increasing body weight in a subject by administering TGF-α
11/26/2002	US6486106 Composition
11/26/2002	US6485973 Oligonucleotides specific for the marORAB operon
11/26/2002	US6485960 Polycystic kidney disease 1 gene and uses thereof
11/26/2002	US6485941 Inhibition of the carboxyltransferase component of acetyl-CoA carboxylase, and the use of such inhibition in anti-cancer and anti-lipogenic therapies
11/26/2002	US6485911 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 2 (PS-2) gene
11/26/2002	US6485760 Method for inhibiting increase of blood sugar level or lowering blood sugar level with a lagerstroemia extract
11/26/2002	US6485758 Charcoal, vitamin b6, ma huang (herb containing ephedrine) and inert, nontoxic carrier
11/26/2002	US6485752 Rose hip extract and fish oil for the treatment of pain and stiffness in the joints, such as associated with osteoarthritis
11/26/2002	US6485745 Dosage form exhibits accelerated release of the active agent
11/26/2002	US6485744 Stabilized cefuroxime axetil
11/26/2002	US6485743 Dissolved itraconazole and hydrophilic polymer with solvent, spray-dried, and prepared into solid dispersion for oral preparation
11/26/2002	US6485742 Process for producing coated preparation and its use
11/26/2002	US6485741 Tablets, capsules
11/26/2002	US6485740 Transdermal methotrexate preparations
11/26/2002	US6485733 Absorbent article composition for sequestering skin irritants
11/26/2002	US6485727 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves
11/26/2002	US6485714 Use of salicylic acid for regulating hyperpigmented spots
11/26/2002	US6485707 Modulated release particles for aerosol delivery
11/26/2002	US6485704 Azo compound for type I pototherapy
11/26/2002	US6485514 Local delivery of therapeutic agents
11/26/2002	CA2355247C Method for the prevention and treatment of cachexia and anorexia
11/26/2002	CA2258285C Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
11/26/2002	CA2257142C 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
11/26/2002	CA2246482C Novel trans-3,4,4a,5,6,10b-hexahydro-2h-naphth¢1,2-b!-1,4-oxazines disubstitutes, process for preparing them and pharmaceutical compounds containing them
11/26/2002	CA2240717C Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
11/26/2002	CA2231364C Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2148103C Process for preparing taxane derivatives
11/26/2002	CA2103580C Orthomolecular method of treating sickle cell disease
11/26/2002	CA2102889C Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2095214C Agents for the treatment of diseases caused by parasitic protozoa and neoplastic diseases
11/26/2002	CA2093203C Pyrimidine derivatives and processes for the preparation thereof
11/26/2002	CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/26/2002	CA2083377C Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna
11/26/2002	CA2078555C Novel vitamin d analogues
11/26/2002	CA2067275C Pharmaceutical formulation containing dirithromycin
11/26/2002	CA2067184C New linker for bioactive agents
11/25/2002	WO2001090087A1 Heterocyclic compounds
11/25/2002	CA2410382A1 Heterocyclic compounds
11/25/2002	CA2348853A1 Novel carborane analogs of tamoxifen
11/24/2002	CA2387007A1 Therapies for tissue damage resulting from ischemia
11/23/2002	CA2386740A1 Combination treatment for alcoholism and alcohol dependence
11/23/2002	CA2386287A1 Combination treatment for depression and anxiety
11/22/2002	WO2003101942A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action
11/22/2002	WO2002094843A1 Crystal forms of azithromycin
11/22/2002	WO2001090079A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
11/22/2002	CA2445571A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
11/22/2002	CA2410304A1 Novel carbamates and ureas production and use thereof as endothelin receptor antagonists
11/21/2002	WO2002093164A2 Pyridylpyrimidine derivatives as effective compounds against prion diseases
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092840A2 Agents that regulate apoptosis
11/21/2002	WO2002092831A2 Method for identifying ligands for g protein coupled receptors

1 ... 5641 5642 5643 5644 5645 5646 5647 5648 5649 5650 5651 5652 5653 5654 5655 5656 5657 5658 5659 5660 5661 ... 7860